Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CorPath GRX With ReMOTE Proof of Principle (POP): First in Human in India

NCT03705481 is registered in ClinicalTrials.gov with Siemens Healthineers Endovascular Robotics, Inc. as lead sponsor.

NCT NCT03705481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03705481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CorPath GRX With ReMOTE Proof of Principle (POP): First in Human in India
Lead sponsor
Siemens Healthineers Endovascular Robotics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 3, 2018
Completion date
December 7, 2018
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

percutaneous coronary intervention